SMTL ID : 6mhr.2 (1 other biounit)

Structure of the human 4-1BB / Urelumab Fab complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- FUC- NAG- FUC: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-FUC-NAG-FUC.1: 3 residues within 4Å: Chain C: V.122, N.125 Ligands: EPE.4 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:V.122

2 x MLI: MALONATE ION(Non-functional Binders)

MLI.2: 5 residues within 4Å: Chain A: G.31, G.100, P.101, G.102, D.105 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:D.105 MLI.3: 3 residues within 4Å: Chain B: K.39, Q.42, R.45 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:Q.42 Salt bridges: B:K.39, B:R.45, B:R.45

1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.4: 6 residues within 4Å: Chain C: T.113, N.114, C.115, S.116, V.122 Ligands: NAG-FUC-NAG-FUC.1 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:N.114, C:C.115, C:S.116

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chin, S.M. et al., Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab. Nat Commun (2018)

Release Date

2018-11-21

Peptides

Urelumab Fab heavy chain: A
Urelumab Fab kappa chain: B
Tumor necrosis factor receptor superfamily member 9: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Urelumab Fab heavy chain

Urelumab Fab kappa chain

Tumor necrosis factor receptor superfamily member 9

Related Entries With Identical Sequence